Nevertheless, to the author’s knowledge, this is the first piece of work that establishes a connection between TGF-β/Smad pathway, IL-1β and IL-6 levels, metabolic pathways, the type of allergy, metabolic dysregulations, and the risk of cancer within a unified framework. Here, TGFB1 is linked to allergic disease.